McKesson (MCK) News
NYSE: MCKHealth CareOther PharmaceuticalsUSD
938.84+8.59 (+0.92%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
MCK news summary
We found 44 recent headlines mentioning McKesson (MCK): 12 in the past week and 28 in the past 30 days, most often from Nasdaq, Seeking Alpha, Investor's Business Daily. For price context, MCK is up 0.92% at $938.84. The most recent story, "Why McKesson (MCK) is a Top Momentum Stock for the Long-Term", was published by Nasdaq on Oct 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest McKesson headlines
- Why McKesson (MCK) is a Top Momentum Stock for the Long-TermWondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.Nasdaq
- If You Invested $1000 in McKesson a Decade Ago, This is How Much It'd Be Worth NowWhy investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.Nasdaq
- Here's Why McKesson (MCK) is a Strong Growth StockWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.Nasdaq
- Is McKesson (MCK) Outperforming Other Medical Stocks This Year?Here is how McKesson (MCK) and Avantor, Inc. (AVTR) have performed compared to their sector so far this year.NasdaqMCK, AVTR
- Is It Worth Investing in McKesson (MCK) Based on Wall Street's Bullish Views?According to the average brokerage recommendation (ABR), one should invest in McKesson (MCK). It is debatable whether this highly sought-after metric is effective because Wall Street analysts'…Nasdaq
- Here's Why McKesson (MCK) Fell More Than Broader MarketIn the closing of the recent trading day, McKesson (MCK) stood at $910.33, denoting a -1.23% move from the preceding trading day.Nasdaq
- Is McKesson (MCK) a Solid Growth Stock? 3 Reasons to Think "Yes"McKesson (MCK) is well positioned to outperform the market, as it exhibits above-average growth in financials.Nasdaq
- Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now?McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.Nasdaq
- Why Option Care Health Stock Skyrocketed on TuesdayKey PointsOption Care is being bought out by McKesson and private equity firm Clayton Dubilier & Rice.NasdaqOPCH, MCK
- Option Health Care Skyrockets On $5.8 Billion McKesson, CD&R TakeoverOption Health Care shares skyrocketed Tuesday after McKesson and CD&R agreed to buy the infusion services company for $5.8 billion. The post Option Health Care Skyrockets On $5.8 Billion…Investor's Business Daily
- OPCH shares jump 34% as CD&R, McKesson agree to $5.8B takeoverSeeking Alpha
- CD&R And McKesson To Acquire Option Care Health(RTTNews) - CD&R, McKesson (MCK) and Option Care Health (OPCH) have entered into a definitive agreement, under which CD&R and McKesson will acquire Option Care Health for $32.05 per share, reflecting…NasdaqMCK, OPCH
- Zacks Industry Outlook Highlights McKesson, Cardinal Health, Becton, Dickinson, Merit Medical Systems and ProDexMedical-dental supplies see durable demand from specialty care, AI and aging trends, with McKesson and peers navigating tariffs and inflation.NasdaqBDX, CAH, MCK, MMSI
- Company News for Oct 2, 2026Companies In The News Are: ACN, AYI, MCK, PRGS.NasdaqACN, MCK, PRGS, AYI
- Why McKesson Stock Soared More Than 5% Higher TodayKey PointsThe arrangement is now in force through June 2032.Nasdaq
- McKesson, Cardinal Health extend distribution agreements with CVS HealthSeeking AlphaCAH, MCK, CVS
- McKesson Extends CVS Health Pact To 2032, Reaffirms FY27 Adj. EPS Guidance(RTTNews) - Pharmaceutical distributor McKesson Corp. (MCK), announced on Thursday that it has signed an agreement in principle to extend its partnership with CVS Health Corp. (CVS) to supply…NasdaqCVS, MCK
- 5 Medical Dental Supply Stocks to Watch as Industry Prospects ImproveHere, we highlight five medical supplies stocks, MCK, CAH, BDX, MMSI and PDEX, with strong potential that investors should keep on their watchlist amid improving industry prospects.NasdaqMCK, BDX, CAH, MMSI
- McKesson (MCK) Sees a More Significant Dip Than Broader Market: Some Facts to KnowMcKesson (MCK) reached $853.81 at the closing of the latest trading day, reflecting a -1.27% change compared to its last close.Nasdaq
- Invesco S&P 500 Revenue ETF Experiences Big OutflowLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Invesco S&P 500 Revenue ETF (Symbol: RWL) where we have detected an…NasdaqRWL, MCK, CVS, COR
- Here's Why You Should Retain McKesson Stock in Your Portfolio for NowMcKesson's specialty distribution, oncology and GLP-1 growth are driving earnings, while drug pricing, margin pressure and policy uncertainty pose challenges.NasdaqMCK, ISRG, GMED, VCYT
- Cardinal Health vs. McKesson: Which Healthcare Stock Is Better?CAH's specialty-led growth, stronger EPS outlook and improving estimate momentum set up a compelling case against MCK.NasdaqCAH, MCK
- Why McKesson (MCK) Dipped More Than Broader Market TodayThe latest trading day saw McKesson (MCK) settling at $880.5, representing a -1.2% change from its previous close.Nasdaq
- McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should KnowZacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.Nasdaq
- Notable ETF Inflow Detected - RWL, MCK, COR, CILooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Invesco S&P 500 Revenue ETF (Symbol: RWL) where we have detected an…NasdaqRWL, MCK, COR, CI
- Can CAH's MSO Expansion Unlock Growth in Specialty Care Delivery?CAH is expanding its MSO strategy across specialty care, with Solaris and broader services aimed at scaling physician networks.NasdaqCAH, MCK, COR
- McKesson Corporation (MCK) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking AlphaMCK, MS
- CAH Gains More Than 29% in 4 Months: Will the Uptrend Continue?Cardinal Health's 29% rally reflects stronger specialty growth, MSO expansion and higher-margin assets, but cost pressures could test the uptrend.NasdaqCAH, MCK, COR
- McKesson Corporation (MCK) Presents at Wells Fargo 21st Annual Healthcare Conference TranscriptSeeking Alpha
- Underestimating The Moat: Why McKesson's Oncology Pivot And Share Buybacks Signal Structural UpsideSeeking Alpha
- Cencora Raises 2026 EPS Outlook as Specialty Businesses StrengthenCencora raised its fiscal 2026 EPS outlook as specialty businesses fueled stronger profit growth despite mix, pricing and financing pressures.NasdaqCOR, CAH, MCK
- McKesson: Solid Q1 Earnings And Management Execution (Rating Upgrade)Seeking Alpha
- McKesson Corporation 2027 Q1 - Results - Earnings Call PresentationSeeking Alpha
- McKesson Corporation (MCK) Q1 2027 Earnings Call TranscriptSeeking Alpha
- After-Hours Earnings Report for August 5, 2026 : SNDK, WDC, APP, MCK, MELI, DASH, MFC, MSI, ALL, MET, O, OXYThe following companies are expected to report earnings after hours on 08/05/2026. Visit our Earnings Calendar for a full list of expected earnings releases.Sandisk Corporation (SNDK)is reporting for…NasdaqSNDK, WDC, APP, MCK
- McKesson Checks All The Boxes To Survive And Prosper In A Weak Economy, But There's A Big CatchSeeking Alpha
- McKesson: The Healthcare Supplier On My Buy List This Summer, As Growth AcceleratesSeeking Alpha
- McKesson Corporation (MCK) Presents at Bank of America Global Healthcare Conference 2026 TranscriptSeeking AlphaMCK, BAC
- McKesson Corporation (MCK) Q4 2026 Earnings Call TranscriptSeeking Alpha
- McKesson Corporation 2026 Q4 - Results - Earnings Call PresentationSeeking Alpha
- McKesson: 'Hold' Still Valid In 2026Seeking Alpha
- McKesson Corporation (MCK) Presents at Barclays 28th Annual Global Healthcare Conference TranscriptSeeking AlphaMCK, BCS
- McKesson Corporation (MCK) Presents at Leerink Global Healthcare Conference 2026 TranscriptSeeking Alpha
- Will Medline's Q4 Earnings Validate Its Prime Vendor Growth Strategy?MDLN is set to report first earnings as a public company, with Prime Vendor growth and brand mix in focus ahead of Q4 results.NasdaqMCK, COO, STAA, MDLN